menu
    • menu

    Company profile for Asahi Kasei Pharma

    NEW Drugs in Dev: 10
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We, the Asahi Kasei Group, contribute to life and living for people around the world. Centered on the operating holding company Asahi Kasei Corp. and six core operating companies, the Asahi Kasei Group operates in the three business sectors of Material, Homes, and Health Care.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Asahi Kasei Pharmajapan Flag
    Country
    Country
    Japan
    Address
    Address
    Hibiya Mitsui Tower 1-1-2 Yurakucho, Chiyoda-ku
    Telephone
    Telephone
    +81-(0)3-6699-3000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.asahikasei-pharma.co.jp/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    India Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    India Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Asahi Kasei Launches PhI Trial for Peptide in Autoimmune Diseases
    Asahi Kasei Launches PhI Trial for Peptide in Autoimmune Diseases

    20 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-20/asahi-kasei-announces-initiation-of-phase-i-clinical-trial-for-novel-peptide-candidate-targeting-aut

    PHARMIWEB
    20 Apr 2026
    Share Share
    Asahi Kasei to buy Germany's Aicuris for $920M
    Asahi Kasei to buy Germany's Aicuris for $920M

    27 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/asahi-kasei-accrue-german-aicuris-920-million-rd-portfolio-boost

    FIERCE BIOTECH
    27 Feb 2026
    Share Share
    Asahi Kasei Inks Global License with Alchemedicine
    Asahi Kasei Inks Global License with Alchemedicine

    25 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-25/asahi-kasei-pharma-strengthens-preclinical-pipeline-through-exclusive-global-license-agreement-with

    PHARMIWEB
    25 Feb 2026
    Share Share
    Asahi Kasei and Alchemedicine Launch Phase I for Refractory
    Asahi Kasei and Alchemedicine Launch Phase I for Refractory

    18 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-18/asahi-kasei-pharma-and-alchemedicine-advance-a-novel-therapeutic-candidate-into-phase-i-study-for-the-treatment-of-refractory-diseases

    PHARMIWEB
    18 Feb 2026
    Share Share
    New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval
    New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval

    10 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260210764283/en/New-ZOLL-Zenix-MonitorDefibrillator-Receives-MDR-Approval

    BUSINESSWIRE
    10 Feb 2026
    Share Share
    Asahi Kasei Pharma To Move R&D Hub To Shonan Ipark In 2027
    Asahi Kasei Pharma To Move R&D Hub To Shonan Ipark In 2027

    24 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/asahi-kasei-pharma-to-move-rd-hub-to-shonan-ipark-in-2027-18671

    INDPHARMAPOST
    24 Dec 2025
    Share Share

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Asahi Kasei Pharma and get a quotation

    Asahi Kasei Pharma is a supplier offers 2 products (APIs, Excipients or Intermediates).

    Find a price of Teriparatide Acetate bulk offered by Asahi Kasei Pharma

    Find a price of Missouri Bean bulk offered by Asahi Kasei Pharma

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search